Got a great research idea? Think you might be on to a patent opportunity? Ever wonder about IP within the UC system? ...Or if you are considering a Career in IP,
don't miss the UCLA Office of Intellectual Property (OIP) seminar on IP Protection, Commercialization and Career Possibilities - Thursday, October 23, 2008, 5-6pm.

Dr. Kathryn Atchison, Vice Provost, Intellectual Property and Industry Relations and Associate Vice Chancellor for Research, will speak about UC guidelines on IP and the avenues available to UC researchers for protecting and commercializing their work.
Those applying for TCA mentorship are strongly encouraged to attend.

There will be a panel to discuss Careers in IP: Speakers include a Patent Agent, UCLA faculty who have experience in tech-commercialization and start-ups, and a Patent Attorney. Please come well-equipped with questions for the panelists!

Light refreshments will be served at a reception after the seminar. This event will be held on campus at the Neuroscience Research Building Auditorium (635 Charles Young Drive South, Los Angeles, CA 90095).
As seating is limited, you must click here to RSVP.

Email cfonseca@mednet.ucla.edu if you have any questions.

Map of Location

Speaker Bios:

Academic - Wenyuan Shi, Ph.D
Dr. Wenyuan Shi is a chairman and professor of Oral Biology at UCLA Schools of Dentistry. Dr. Shi’s laboratory has been using multidisciplinary approaches to study oral microbial pathogenesis with a specific focus on microbial biofilm, inter-species interaction and signal transduction. In addition, Dr. Shi’s laboratory is actively involved in the development of next generation of diagnostic and therapeutic tools against oral microbial infections, including instant chairside detection of oral pathogens and peptide based targeted antimicrobial therapeutics. These translational research efforts have resulted in novel technologies that are licensed and developed by major pharmaceutical, dental and biotech companies. Dr. Shi is also the founding scientist and chairman of the scientific advisory board of C3 Jian Inc. (www.c3-jian.com).
Dr. Shi obtained his BS degree from Fudan University (Shanghai) in 1984, acquired his Ph.D degree from University of Wisconsin-Madison in 1991 and fulfilled his postdoctoral training at University of California-Berkeley during 1992-1995. He is co-author and co-inventor of over 130 scientific articles and patents.

IP Attorney - Carter, Scott, Ph.D, J.D.
Scott Carter is an attorney in the Los Angeles office of Latham & Watkins. His practice involves the representation of biotechnology, medical device and other life science and technology companies in a wide range of intellectual property and technology-based transactions, including licensing, corporate partnering and technology development, as well as providing strategic intellectual property advice. Prior to joining Latham & Watkins, Scott was the Assistant Director of the Office of Technology Transfer at the California Institute of Technology. Scott managed Caltech's Life Science patent portfolio and negotiated and drafted license agreements, research agreements and material transfer agreements. Prior to his work at Caltech, Scott was a patent agent at a California law firm where he drafted and prosecuted biotechnology patent applications. Scott graduated summa cum laude from Amherst College with a degree in Biochemistry, and received a Ph.D. in Chemistry from Caltech in the laboratory of Peter Dervan, where his research focused on the design, synthesis and testing of DNA binding molecules. Scott received his law degree from UCLA.

Patent Agent - Auyoung, Sandy, M.S.
Sandy Auyoung joined OIP-ISR as Technology Transfer Officer. In her position, Ms. Auyoung is responsible for managing inventions and assessing their patentability and commercial viabilities. Previous to her employment at OIP-ISR, Ms. Auyoung worked at Pathway Diagnostics Corporation doing patent management and business development. Her role at Pathway was to ensure that licensed patents protect the most commercially relevant aspects of the company’s final products – biomarkers for use in the clinical setting. Ms. Auyoung is also a registered patent agent at the United States Patent Trademark Office and has experience in prosecuting patents. She received a Master of Bioscience from the Keck Graduate Institute where her expertise focused in gene expression analysis. She interned at Genentech and worked on validating Illumina’s bead array technology with conventional slide format. She is an alumnus of UCLA’s undergraduate program in Microbiology, Immunology, and Molecular Genetics. Ms. Auyoung was a candidate of the UCLA Anderson School of Management’s Knapp Business Plan Competition for 2007 and 2008. Her teams, ShowTag and Synlixir, entered the semifinal in 2007 and finished 3rd place in 2008, respectively. She previously worked in OIP-ISR from 2002 to 2005, initially as a summer intern and then as a marketing analyst.

Business and Finance - Weinstein, Earl Ph.D
Dr. Weinstein is Assistant Director of UCLA’s technology transfer office and joined the technology transfer group at UCLA from PureTech Ventures, a seed stage venture capital firm in Boston. At PureTech he spent four years sourcing, evaluating and managing investments in life sciences startups spun directly out of research institutions. He also spent two years doing business development for Cellicon Biotechnologies. He is now working with scientists and engineers at UCLA who are interested in starting companies to advance the development of their technologies as well as developing licensing deals around more mature technologies with existing technology companies.
Prior to joining PureTech Ventures, Dr. Weinstein completed a PhD at MIT working on computational and experimental analysis of a novel form of gene regulation that was published in Science and awarded the AAAS Newcomb-Cleveland Prize. He has also done work in materials science and computer modeling of semiconductors at the University of Pennsylvania during his undergraduate degree.